Press Releases

Press Releases
Date	Title	View
Jul 5, 2017	Second Sight Announces Market Entry into South Korea with Two Implants and Performs Second Implant in Taiwan of Argus II Retinal Prosthesis System -Marks Continued Expansion of Argus II in Asia- SYLMAR, Calif.--(BUSINESS WIRE)-- Second Sight Medical Products, Inc. (NASDAQ:EYES) ("Second Sight" or "the Company"), a developer, manufacturer and marketer of implantable visual prosthetics to provide useful vision to blind patients, today ...	PDF Add to Briefcase File is in Briefcase
Jul 3, 2017	Second Sight Announces Expansion of Medicare Coverage for Argus II Retinal Prosthesis System to 11 Additional States and the District of Columbia -- Argus II Can Now Be Covered in Seven of 12 Medicare Administrative Contractor Jurisdictions, representing a total of 28 states, two territories, and the District of Columbia -- SYLMAR, Calif.--(BUSINESS WIRE)-- Second Sight Medical Products, Inc. (NASDAQ:EYES) ("Second Sight" or ...	PDF Add to Briefcase File is in Briefcase
May 17, 2017	Second Sight to Present at 18th Annual B. Riley & Co. Institutional Investor Conference SYLMAR, Calif.--(BUSINESS WIRE)-- Second Sight Medical Products, Inc. (NASDAQ:EYES) ("Second Sight"), a developer, manufacturer and marketer of implantable visual prosthetics that are intended to provide some useful vision to blind patients, today announced that Will McGuire, President and Chief Executive Officer...	PDF Add to Briefcase File is in Briefcase
May 3, 2017	Second Sight Reports First Quarter 2017 Financial Results SYLMAR, Calif.--(BUSINESS WIRE)-- Second Sight Medical Products, Inc. (NASDAQ:EYES) ("Second Sight" or "the Company"), a developer, manufacturer and marketer of implantable visual prosthetics to provide some useful vision to blind patients, today reported financial results for the three-months ended March 31, ...	PDF Add to Briefcase File is in Briefcase
Apr 25, 2017	Second Sight to Discuss First Quarter 2017 Financial Results on May 3, 2017 Conference Call SYLMAR, Calif.--(BUSINESS WIRE)-- Second Sight Medical Products, Inc. (NASDAQ:EYES), a developer, manufacturer and marketer of implantable visual prosthetics that are intended to provide some useful vision to blind patients, will release its first quarter financial results on Wednesday, May 3, 2017, after the ...	PDF Add to Briefcase File is in Briefcase
Apr 13, 2017	Second Sight's Argus II Retinal Prosthesis Implanted in First Patient in Asia --Underscores Second Sight's Commitment to Expansion in Asia-- SYLMAR, Calif.--(BUSINESS WIRE)-- Second Sight Medical Products, Inc. (NASDAQ:EYES) ("Second Sight" or "the Company"), a developer, manufacturer and marketer of implantable visual prosthetics that are intended to provide some use...	PDF Add to Briefcase File is in Briefcase
Apr 6, 2017	Second Sight Announces Dr. Robert Greenberg, Chairman, Inducted as a National Academy of Inventors Fellow -Highest Professional Distinction Accorded to Inventors Demonstrating a Prolific Spirit of Innovation- SYLMAR, Calif.--(BUSINESS WIRE)-- Second Sight Medical Products, Inc. (NASDAQ: EYES), ("Second Sight" or the "Company"), a developer, manufacturer and marketer of implantable visua...	PDF Add to Briefcase File is in Briefcase
Mar 27, 2017	Second Sight Medical Products, Inc. Announces Warrants Approved for Listing on Nasdaq With Trading Scheduled to Commence March 29 under Symbol "EYESW" SYLMAR, Calif.--(BUSINESS WIRE)-- Second Sight Medical Products, Inc. (NASDAQ:EYES), (the "Company"), a developer, manufacturer and marketer of implantable visual prosthetics that provide some useful vision to blind patients, today announced that warrants issued in connection with its recent oversubscribed rights...	PDF Add to Briefcase File is in Briefcase
Mar 9, 2017	Second Sight Reports Fourth Quarter and Year End 2016 Financial Results SYLMAR, Calif.--(BUSINESS WIRE)-- Second Sight Medical Products, Inc. (NASDAQ:EYES) ("Second Sight" or "the Company"), a developer, manufacturer and marketer of implantable visual prosthetics to provide some useful vision to blind patients, today reported financial results for the three- and twelve-month periods ...	PDF Add to Briefcase File is in Briefcase
Mar 9, 2017	Second Sight Medical Products, Inc. Announces Completion of Oversubscribed Rights Offering SYLMAR, Calif.--(BUSINESS WIRE)-- Second Sight Medical Products, Inc. (NASDAQ:EYES) ("Second Sight" or "the Company"), a developer, manufacturer and marketer of implantable visual prosthetics that provide some useful vision to blind patients, today announced that it has completed its previously announced rights ...	PDF Add to Briefcase File is in Briefcase
Mar 2, 2017	Second Sight Appoints David Jacques as Vice President of Research and Development SYLMAR, Calif.--(BUSINESS WIRE)-- Second Sight Medical Products, Inc. (NASDAQ:EYES) ("Second Sight" or "the Company"), a developer, manufacturer and marketer of implantable visual prosthetics that provide some useful vision to blind patients, today announced the appointment of David Jacques as Vice President of ...	PDF Add to Briefcase File is in Briefcase
Mar 1, 2017	Second Sight to Discuss Fourth Quarter and Year-End 2016 Financial Results on March 9, 2017 Conference Call SYLMAR, Calif.--(BUSINESS WIRE)-- Second Sight Medical Products, Inc. (NASDAQ: EYES), a developer, manufacturer and marketer of implantable visual prosthetics to provide some useful vision to blind patients, will release its fourth quarter and year-end financial results on Thursday, March 9, 2017, after the ...	PDF Add to Briefcase File is in Briefcase
Feb 21, 2017	Second Sight Announces Professor Stanislao Rizzo Has Completed His 30th Implant of the Argus II Retinal Prosthesis SYLMAR, Calif.--(BUSINESS WIRE)-- Second Sight Medical Products, Inc. (Nasdaq:EYES), ("Second Sight" or "the Company"), a developer, manufacturer and marketer of implantable visual prosthetics to provide some useful vision to blind patients, today announced that Professor Stanislao Rizzo (Professor Rizzo...	PDF Add to Briefcase File is in Briefcase
Feb 6, 2017	Second Sight Medical Products, Inc. Announces Record Date, Subscription Pricing, Expiration Date for Rights Offering and Effectiveness of Its Registration Statement SYLMAR, Calif.--(BUSINESS WIRE)-- Second Sight Medical Products, Inc. (Nasdaq:EYES), ("Second Sight" or "the Company"), a developer, manufacturer and marketer of implantable visual prosthetics to provide some useful vision to blind patients, today announced that it has set 5:00 p.m. Eastern Time on Febru...	PDF Add to Briefcase File is in Briefcase
Feb 2, 2017	Second Sight Announces Positive Reimbursement Renewal Decision in Germany SYLMAR, Calif.--(BUSINESS WIRE)-- Second Sight Medical Products, Inc. (Nasdaq:EYES) ("Second Sight" or "the Company"), a developer, manufacturer and marketer of implantable visual prosthetics to restore some functional vision to blind patients, today announced that the German Institute for the Hospital Remunerati...	PDF Add to Briefcase File is in Briefcase
Jan 9, 2017	Second Sight Medical Products, Inc. Announces Rights Offering SYLMAR, Calif.--(BUSINESS WIRE)-- Second Sight Medical Products, Inc. (Nasdaq:EYES) ("Second Sight" or "the Company"), a developer, manufacturer and marketer of implantable visual prosthetics to provide some useful vision to blind patients, today announced it filed a registration statement on Form S-1 wi...	PDF Add to Briefcase File is in Briefcase
Dec 22, 2016	UK Government Announces Funding for Second Sight's Argus II "Bionic Eye" SYLMAR, Calif. & LAUSANNE, Switzerland--(BUSINESS WIRE)-- Second Sight Medical Products, Inc. (Nasdaq:EYES) ("Second Sight"), a developer, manufacturer and marketer of implantable visual prosthetics to provide some useful vision to blind patients suffering from Retinitis Pigmentosa (RP), today announced, followin...	PDF Add to Briefcase File is in Briefcase
Nov 22, 2016	Second Sight to Present at the 9th Annual LD Micro Main Event LOS ANGELES, CA / ACCESSWIRE / November 22, 2016 / Second Sight Medical Products, Inc. (NASDAQ: EYES) ("Second Sight" or "the Company"), a developer, manufacturer, and marketer of implantable visual prosthetics to provide a form of useful vision to blind patients, announced today that it will be presenting at the 9th annual LD Micro Main Event on W...	PDF Add to Briefcase File is in Briefcase
Nov 2, 2016	Second Sight Reports Third Quarter 2016 Financial Results SYLMAR, Calif.--(BUSINESS WIRE)-- Second Sight Medical Products, Inc. (NASDAQ:EYES) ("Second Sight" or "the Company"), a developer, manufacturer and marketer of implantable visual prosthetics to provide a form of useful vision to blind patients, today reported financial results for the three- and nine-month perio...	PDF Add to Briefcase File is in Briefcase
Nov 2, 2016	Second Sight Announces Final CMS Hospital Outpatient Payment Rate for 2017 and Two New CPT Codes for Programming the Argus II Retinal Prosthesis System SYLMAR, Calif.--(BUSINESS WIRE)-- Second Sight Medical Products, Inc. (NASDAQ:EYES) ("Second Sight"), a developer, manufacturer and marketer of implantable visual prosthetics that provide a form of useful vision to blind patients, today announced that the Centers for Medicare & Medicaid Services (CMS) finalized i...	PDF Add to Briefcase File is in Briefcase
Oct 26, 2016	Second Sight to Discuss Third Quarter 2016 Financial Results on November 2, 2016 Conference Call SYLMAR, Calif.--(BUSINESS WIRE)-- Second Sight Medical Products, Inc. (NASDAQ:EYES), a developer, manufacturer and marketer of implantable visual prosthetics to provide some useful vision to blind patients, will release its third quarter 2016 financial results on Wednesday, November 2, 2016, after the close ...	PDF Add to Briefcase File is in Briefcase
Oct 25, 2016	Second Sight Announces Successful Implantation and Activation of Wireless Visual Cortical Stimulator in First Human Subject Provides Proof of Concept for the Ongoing Development of the Orion™ I Visual Cortical Prosthesis SYLMAR, Calif.--(BUSINESS WIRE)-- Second Sight Medical Products, Inc. (NASDAQ:EYES) (Second Sight or the Company), a developer, manufacturer and marketer of implantable visual pros...	PDF Add to Briefcase File is in Briefcase
Oct 13, 2016	Second Sight to Present at The MicroCap Conference on October 25, 2016 SYLMAR, CA / ACCESSWIRE / October 13, 2016 / Second Sight Medical Products, Inc. (NASDAQ: EYES) ("Second Sight" or "the Company"), a developer, manufacturer and marketer of implantable visual prosthetics to provide some useful vision to blind patients, will present at The MicroCap Conference being held October 24-25, 2016 at the Hotel Monaco in Phi...	PDF Add to Briefcase File is in Briefcase
Sep 2, 2016	Second Sight to Present at the Rodman & Renshaw 18th Annual Global Investment Conference on September 13, 2016 SYLMAR, Calif.--(BUSINESS WIRE)-- Second Sight Medical Products, Inc. (NASDAQ:EYES) ("Second Sight" or "the Company"), a developer, manufacturer and marketer of implantable visual prosthetics to provide some useful vision to blind patients, will present at the Rodman & Renshaw 18th Annual Global Investment Confer...	PDF Add to Briefcase File is in Briefcase
Jul 28, 2016	Second Sight Reports Second Quarter 2016 Financial Results SYLMAR, Calif.--(BUSINESS WIRE)-- Second Sight Medical Products, Inc. (NASDAQ:EYES) ("Second Sight" or "the Company"), a developer, manufacturer and marketer of implantable visual prosthetics to provide some useful vision to blind patients, today reported financial results for the three- and six-month periods ...	PDF Add to Briefcase File is in Briefcase
Jul 28, 2016	Second Sight Announces Two Exclusive Distribution Agreements to Bring the Argus II Retinal Prosthesis to Taiwan and Iran SYLMAR, Calif.--(BUSINESS WIRE)-- Second Sight Medical Products, Inc. (NASDAQ:EYES) ("Second Sight" or "the Company"), a developer, manufacturer and marketer of implantable visual prosthetics to restore some useful vision to blind patients, today announced plans to expand into Taiwan with Orient Europharma Co, ...	PDF Add to Briefcase File is in Briefcase
Jul 21, 2016	Second Sight Announces Positive Five-Year Data from Argus II Retinal Prosthesis System Study Results Published in Ophthalmology Show Safety and Sustained Improvement in Visual Performance for Blind Patients SYLMAR, Calif.--(BUSINESS WIRE)-- Second Sight Medical Products, Inc. (NASDAQ:EYES) ("Second Sight"), the developer, manufacturer and marketer of implantable visual prosthe...	PDF Add to Briefcase File is in Briefcase
Jul 21, 2016	Second Sight to Discuss Second Quarter 2016 Financial Results on July 28, 2016 Conference Call SYLMAR, Calif.--(BUSINESS WIRE)-- Second Sight Medical Products, Inc. (NASDAQ:EYES), a developer, manufacturer and marketer of implantable visual prosthetics to provide some useful vision to blind patients, will release its second quarter 2016 financial results on Thursday, July 28, 2016, after the close of ...	PDF Add to Briefcase File is in Briefcase
Jun 1, 2016	Second Sight Medical Products, Inc. Announces Completion of Oversubscribed Rights Offering SYLMAR, Calif.--(BUSINESS WIRE)-- Second Sight Medical Products, Inc. (NASDAQ:EYES) ("Second Sight" or "the Company"), a developer, manufacturer and marketer of implantable visual prosthetics to provide some useful vision to blind patients, today announced that it has completed its previously announced rights ...	PDF Add to Briefcase File is in Briefcase
May 9, 2016	Second Sight Files S-1 Registration Statement for Rights Offering to Shareholders and Sets Record Date SYLMAR, Calif.--(BUSINESS WIRE)-- Second Sight Medical Products, Inc. (Nasdaq:EYES) ("Second Sight" or "the Company"), a developer, manufacturer and marketer of implantable visual prosthetics to provide some useful vision to blind patients, today announced that it has set 5:00 p.m. Eastern Time on May 13...	PDF Add to Briefcase File is in Briefcase
Apr 28, 2016	Second Sight Reports First Quarter 2016 Financial Results SYLMAR, Calif.--(BUSINESS WIRE)-- Second Sight Medical Products, Inc. (NASDAQ: EYES) ("Second Sight" or "the Company"), a developer, manufacturer and marketer of implantable visual prosthetics to provide some useful vision to blind patients, today reported financial results for the three-month period ended March ...	PDF Add to Briefcase File is in Briefcase
Apr 20, 2016	Second Sight to Discuss First Quarter 2016 Financial Results on April 28, 2016 Conference Call SYLMAR, Calif.--(BUSINESS WIRE)-- Second Sight Medical Products, Inc. (NASDAQ:EYES), a developer, manufacturer and marketer of implantable visual prosthetics to provide some useful vision to blind patients, will release its first quarter 2016 financial results on Thursday, April 28, 2016, after the close of ...	PDF Add to Briefcase File is in Briefcase
Mar 24, 2016	Second Sight Appoints Steven D. Okland Jr. as Commercial Vice President, U.S. and Canada SYLMAR, Calif.--(BUSINESS WIRE)-- Second Sight Medical Products, Inc. (NASDAQ:EYES) ("Second Sight" or "the Company"), a developer, manufacturer and marketer of implantable visual prosthetics that provide some useful vision to blind patients, today announced the appointment of Steven D. Okland Jr. to Commercial ...	PDF Add to Briefcase File is in Briefcase
Mar 7, 2016	Second Sight to Present at the 28th Annual ROTH Conference on March 14, 2016 SYLMAR, Calif.--(BUSINESS WIRE)-- Second Sight Medical Products, Inc. (NASDAQ:EYES) ("Second Sight" or "the Company"), a developer, manufacturer and marketer of implantable visual prosthetics to provide some useful vision to blind patients, today announced that Will McGuire, President and Chief Executive ...	PDF Add to Briefcase File is in Briefcase
Mar 3, 2016	Second Sight Reports Fourth Quarter and Year End 2015 Financial Results SYLMAR, Calif.--(BUSINESS WIRE)-- Second Sight Medical Products, Inc. (NASDAQ: EYES) ("Second Sight" or "the Company"), a developer, manufacturer and marketer of implantable visual prosthetics to provide some useful vision to blind patients, today reported financial results for the three-month and twelve-month ...	PDF Add to Briefcase File is in Briefcase
Feb 29, 2016	Second Sight to Discuss Fourth Quarter and Year End 2015 Financial Results on March 3, 2016 Conference Call SYLMAR, Calif.--(BUSINESS WIRE)-- Second Sight Medical Products, Inc. (NASDAQ:EYES), a developer, manufacturer and marketer of implantable visual prosthetics to provide some useful vision to blind patients, will release its fourth quarter and year end 2015 financial results on Thursday, March 3, 2016, after ...	PDF Add to Briefcase File is in Briefcase
Feb 26, 2016	Second Sight Mourns Loss and Celebrates Legacy of Founder Alfred E. Mann SYLMAR, Calif.--(BUSINESS WIRE)-- Second Sight Medical Products, Inc. (NASDAQ: EYES) ("Second Sight" or "the Company"), a developer, manufacturer and marketer of implantable visual prosthetics to provide some useful vision to blind patients, today mourns the passing of Founder Alfred E. Mann. ...	PDF Add to Briefcase File is in Briefcase
Feb 23, 2016	Second Sight to Announce Five-Year Data from Argus II Clinical Trial Program Study Results Will Be Presented at 39th Annual Macula Society Meeting SYLMAR, Calif.--(BUSINESS WIRE)-- Second Sight Medical Products, Inc. (NASDAQ:EYES) ("Second Sight" or "the Company"), a developer, manufacturer and marketer of implantable visual prosthetics to provide s...	PDF Add to Briefcase File is in Briefcase
Feb 16, 2016	Second Sight Announces Publication of Positive Results in 3-Year FLORA Study of the Argus II SYLMAR, Calif.--(BUSINESS WIRE)-- Second Sight Medical Products, Inc. ("Second Sight" or "the Company") (Nasdaq:EYES), a developer, manufacturer and marketer of implantable visual prosthetics to restore some useful vision to blind patients, today announced the publication of a positive 3-year FLORA study in the ...	PDF Add to Briefcase File is in Briefcase
Feb 10, 2016	Second Sight to Present at RBC Capital Markets 2016 Global Healthcare Conference and Host Meetings at 2016 BTIG MedTech Conference SYLMAR, Calif.--(BUSINESS WIRE)-- Second Sight Medical Products, Inc. ("Second Sight" or "the Company") (NASDAQ:EYES), a developer, manufacturer and marketer of implantable visual prosthetics to provide some useful vision to blind patients, today announced that Dr. Robert Greenberg, Chairman, and Will McGuire, ...	PDF Add to Briefcase File is in Briefcase
Feb 9, 2016	Second Sight Announces Exclusive Agreement with Tecnosalud to Bring the Argus II Retinal Prosthesis to Argentina SYLMAR, Calif.--(BUSINESS WIRE)-- Second Sight Medical Products, Inc. ("Second Sight" or "the Company") (Nasdaq:EYES), a developer, manufacturer and marketer of implantable visual prosthetics to restore some useful vision to blind patients, today announced plans to expand into South America by signing an ...	PDF Add to Briefcase File is in Briefcase
Jan 25, 2016	Second Sight Files S-1 Registration Statement for Rights Offering to Shareholders SYLMAR, Calif.--(BUSINESS WIRE)-- Second Sight Medical Products, Inc. (NASDAQ:EYES) ("Second Sight" or "the Company"), a developer, manufacturer and marketer of implantable visual prosthetics to provide some useful vision to blind patients, today announced it filed a registration statement on Form S-1 with the ...	PDF Add to Briefcase File is in Briefcase
Jan 11, 2016	Second Sight Provides Business Update and Key Performance Metrics for Full Year 2015 Record Level of Argus II Implants in Fourth Quarter and 2015; Poised for Continued Growth in 2016 SYLMAR, Calif.--(BUSINESS WIRE)-- Second Sight Medical Products, Inc. (NASDAQ:EYES) ("Second Sight" or "the Company"), a developer, manufacturer and marketer of implantable visual prost...	PDF Add to Briefcase File is in Briefcase
Dec 4, 2015	Second Sight Medical Products, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) SYLMAR, Calif.--(BUSINESS WIRE)-- Second Sight Medical Products, Inc. (NASDAQ:EYES) ("Second Sight" or "the Company"), a developer, manufacturer and marketer of implantable visual prosthetics to provide some useful vision to blind patients, announced today that on December 1, 2015, the Board of Directors ...	PDF Add to Briefcase File is in Briefcase
Nov 24, 2015	Second Sight to Present at Piper Jaffray 27th Annual Healthcare Conference SYLMAR, Calif.--(BUSINESS WIRE)-- Second Sight Medical Products, Inc. (NASDAQ:EYES) ("Second Sight" or "the Company"), a developer, manufacturer and marketer of implantable visual prosthetics to provide some useful vision to blind patients, announced today that Will McGuire, President and Chief Executive ...	PDF Add to Briefcase File is in Briefcase
Oct 29, 2015	Second Sight Reports Third Quarter 2015 Financial Results SYLMAR, Calif.--(BUSINESS WIRE)-- Second Sight Medical Products, Inc. (NASDAQ:EYES) ("Second Sight" or "the Company"), a developer, manufacturer and marketer of implantable visual prosthetics to provide some useful vision to blind patients, today reported financial results for the three-month and nine-month ...	PDF Add to Briefcase File is in Briefcase
Oct 19, 2015	Second Sight to Discuss 2015 Third Quarter Financial Results on October 29, 2015 Conference Call SYLMAR, Calif.--(BUSINESS WIRE)-- Second Sight Medical Products, Inc. (NASDAQ:EYES), a developer, manufacturer and marketer of implantable visual prosthetics to provide some useful vision to blind patients, will release its 2015 third quarter results on Thursday, October 29, 2015, after the close of the ...	PDF Add to Briefcase File is in Briefcase
Aug 31, 2015	Second Sight to Present at the Rodman & Renshaw 17th Annual Global Investment Conference SYLMAR, Calif.--(BUSINESS WIRE)-- Second Sight Medical Products, Inc. (NASDAQ: EYES) ("Second Sight" or "the Company"), a developer, manufacturer and marketer of implantable visual prosthetics to provide some useful vision to blind patients, today announced that the Company will present at the Rodman & Renshaw 17...	PDF Add to Briefcase File is in Briefcase
Aug 4, 2015	Second Sight Reports Second Quarter 2015 Financial Results SYLMAR, Calif.--(BUSINESS WIRE)-- Second Sight Medical Products, Inc. (NASDAQ:EYES) ("Second Sight" or "the Company"), a developer, manufacturer and marketer of implantable visual prosthetics to provide some useful vision to blind patients, today reported financial results for the three-month period ended June ...	PDF Add to Briefcase File is in Briefcase
Jul 27, 2015	Second Sight to Discuss 2015 Second Quarter Financial Results on August 4, 2015 Conference Call SYLMAR, Calif.--(BUSINESS WIRE)-- Second Sight Medical Products, Inc. (NASDAQ:EYES) will release its 2015 second quarter results on Tuesday, August 4, 2015, after the close of the U.S. financial markets. Dr. Robert Greenberg, President and Chief Executive Officer, and Tom Miller, Chief Fi...	PDF Add to Briefcase File is in Briefcase
Jul 22, 2015	Second Sight Announces First Age-Related Macular Degeneration Patient Receives the Argus II Retinal Prosthesis System as Part of Groundbreaking Study Five Patients to be Implanted with the Argus® II to Evaluate the Feasibility of the Device in Patients with Dry Age-Related Macular Degeneration SYLMAR, Calif.--(BUSINESS WIRE)-- Second Sight Medical Products, Inc. (Nasdaq:EYES) ("Second Sight" or "the Company"), a developer, m...	PDF Add to Briefcase File is in Briefcase
Jul 15, 2015	Second Sight Announces Expansion of Argus II Availability in Europe SYLMAR, Calif.--(BUSINESS WIRE)-- Second Sight Medical Products, Inc. (NASDAQ:EYES) ("Second Sight" or "the Company"), a developer, manufacturer and marketer of implantable visual prosthetics to provide some useful vision to blind patients, today announced the first commercial implants of the Argus® II Retin...	PDF Add to Briefcase File is in Briefcase
Jun 25, 2015	Second Sight Appoints Will McGuire as President and CEO Dr. Robert Greenberg appointed Chairman of the Board of Directors Dr. Alfred Mann assumes role of Chairman Emeritus SYLMAR, Calif.--(BUSINESS WIRE)-- Second Sight Medical Products, Inc. (NASDAQ:EYES) ("Second Sight" or "the Company"), a developer, manufacturer and marketer of...	PDF Add to Briefcase File is in Briefcase
Jun 23, 2015	Second Sight Announces Positive Long-Term Results of the Argus II Retinal Prosthesis System Study Results Published in Top-Tier Journal Ophthalmology SYLMAR, Calif.--(BUSINESS WIRE)-- Second Sight Medical Products, Inc. (NASDAQ:EYES) ("Second Sight" or "the Company"), a developer, manufacturer and marketer of implantable visual prosthetics to provide some useful vision to blind pat...	PDF Add to Briefcase File is in Briefcase
Jun 16, 2015	Second Sight to Present at JMP Securities Life Sciences Conference SYLMAR, Calif., June 16, 2015 (GLOBE NEWSWIRE) -- Second Sight Medical Products, Inc. (Nasdaq:EYES) ("Second Sight" or "the Company"), a developer, manufacturer and marketer of implantable visual prosthetics to provide functional vision to blind patients, today announced that Dr. Robert Greenberg, President and Chief Executive Officer, will present...	PDF Add to Briefcase File is in Briefcase
Jun 3, 2015	Second Sight Appoints Matthew J. Pfeffer to Its Board of Directors SYLMAR, Calif.--(BUSINESS WIRE)-- Second Sight Medical Products, Inc. (NASDAQ:EYES) ("Second Sight" or "the Company"), a developer, manufacturer and marketer of implantable visual prosthetics that provide functional vision to blind patients, today announced that Matthew J. Pfeffer, Corporate Vice President and ...	PDF Add to Briefcase File is in Briefcase
May 27, 2015	Second Sight to Present at Investor Conference on June 4, 2015 SYLMAR, Calif.--(BUSINESS WIRE)-- Second Sight Medical Products, Inc. (NASDAQ:EYES) ("Second Sight" or "the Company"), a developer, manufacturer and marketer of implantable visual prosthetics to provide functional vision to blind patients, today announced that the Company will present at the Three Part Advisors E...	PDF Add to Briefcase File is in Briefcase
May 13, 2015	Second Sight Reports First Quarter 2015 Financial Results SYLMAR, Calif.--(BUSINESS WIRE)-- Second Sight Medical Products, Inc. (NASDAQ:EYES) ("Second Sight" or "the Company"), a developer, manufacturer and marketer of implantable visual prosthetics to provide functional vision to blind patients, today reported financial results for the three-month period ended March 31...	PDF Add to Briefcase File is in Briefcase
May 7, 2015	Second Sight Announces Exclusive Agreement With Gulf Medical Company to Distribute the Argus II Retinal Prosthesis System in Saudi Arabia SYLMAR, Calif., May 7, 2015 (GLOBE NEWSWIRE) -- Second Sight Medical Products, Inc. ("Second Sight" or "the Company") (Nasdaq:EYES), a developer, manufacturer and marketer of implantable visual prosthetics to restore some useful vision to blind patients, has signed an exclusive agreement with Gulf Medical Company ("Gulf Medical"), one of the larges...	PDF Add to Briefcase File is in Briefcase
May 1, 2015	Second Sight Announces Senior Management Appointments in Commercialization and Manufacturing SYLMAR, Calif.--(BUSINESS WIRE)-- Second Sight Medical Products, Inc. (NASDAQ:EYES) ("Second Sight" or "the Company"), a developer, manufacturer and marketer of implantable visual prosthetics to restore functional vision to blind patients, today announced two senior management appointments in commercialization an...	PDF Add to Briefcase File is in Briefcase
Apr 28, 2015	Second Sight to Discuss 2015 First Quarter Financial Results on May 13, 2015 Conference Call SYLMAR, Calif.--(BUSINESS WIRE)-- Second Sight Medical Products, Inc. (NASDAQ:EYES) will release its 2015 first quarter results on Wednesday, May 13, 2015, after the close of the U.S. financial markets. Dr. Robert Greenberg, President and Chief Executive Officer, and Tom Miller, Chief Fin...	PDF Add to Briefcase File is in Briefcase
Apr 8, 2015	Second Sight Announces First Successful Implant of Model of Orion I Visual Cortical Prosthesis SYLMAR, Calif., April 8, 2015 (GLOBE NEWSWIRE) -- Second Sight Medical Products, Inc. (Nasdaq:EYES) ("Second Sight" or "the Company"), a developer, manufacturer and marketer of implantable visual prosthetics to restore functional vision to blind patients, today announced the first successful implant of a mechanical model of the Orion™ I Visua...	PDF Add to Briefcase File is in Briefcase
Mar 11, 2015	Second Sight Reports Fourth Quarter and Year End 2014 Financial Results and Provides Business Update SYLMAR, Calif.--(BUSINESS WIRE)-- Second Sight Medical Products, Inc. (NASDAQ:EYES) ("Second Sight" or "the Company"), a leading developer, manufacturer and marketer of implantable visual prosthetics to provide functional vision to blind patients, today reported financial results for the three- and twelve- ...	PDF Add to Briefcase File is in Briefcase
Mar 5, 2015	Second Sight Announces Successful First Implants of the Argus® II Retinal Prosthesis System at Two New Centers in Italy SYLMAR, Calif.--(BUSINESS WIRE)-- Second Sight Medical Products, Inc. (Nasdaq: EYES) ("Second Sight" or "the Company"), a developer, manufacturer and marketer of implantable visual prosthetics to provide functional vision to blind patients, today announced that two newly approved centers, located in Camposampiero...	PDF Add to Briefcase File is in Briefcase
Feb 27, 2015	Second Sight to Discuss Fourth Quarter and Year-End 2014 Financial Results on March 11, 2015 Conference Call SYLMAR, Calif.--(BUSINESS WIRE)-- Second Sight Medical Products, Inc. (NASDAQ:EYES) will release its 2014 fourth quarter and year-end financial results on Wednesday, March 11, 2015, after the close of the U.S. financial markets. Dr. Robert Greenberg, President and Chief Executive Officer, and Tom ...	PDF Add to Briefcase File is in Briefcase
Feb 24, 2015	Second Sight Announces First Commercial Implants of the Argus® II Retinal Prosthesis System in France SYLMAR, Calif.--(BUSINESS WIRE)-- Second Sight Medical Products, Inc. (Nasdaq:EYES) ("Second Sight" or "the Company"), a developer, manufacturer and marketer of implantable visual prosthetics to provide functional vision to blind patients, today announced that all three of the centers approved to implant the Argu...	PDF Add to Briefcase File is in Briefcase
Feb 23, 2015	Second Sight to Present at the 27th Annual ROTH Conference on March 9, 2015 SYLMAR, Calif.--(BUSINESS WIRE)-- Second Sight Medical Products, Inc. (NASDAQ:EYES) ("Second Sight" or "the Company"), a developer, manufacturer and marketer of implantable visual prosthetics to provide functional vision to blind patients, today announced that Dr. Robert Greenberg, President and Chief Executive ...	PDF Add to Briefcase File is in Briefcase
Feb 3, 2015	Second Sight Receives Highest Priority Reimbursement for Argus II in Germany SYLMAR, Calif.--(BUSINESS WIRE)-- Second Sight Medical Products, Inc. (Nasdaq:EYES) ("Second Sight" or "the Company"), a developer, manufacturer and marketer of implantable visual prosthetics to provide functional vision to blind patients, today announced that InEK1, the German national system which prov...	PDF Add to Briefcase File is in Briefcase
Jan 12, 2015	Health Canada Approves Second Sight's Argus II Retinal Prosthesis System for Treatment of Outer Retinal Degeneration Argus II is the First Approved ‘Bionic Eye' in Canada for the Treatment of Blindness due to Outer Retinal Degeneration SYLMAR, Calif.--(BUSINESS WIRE)-- Second Sight Medical Products, Inc. (Nasdaq: EYES) ("Second Sight" or "the Company"), a developer, manufacturer and marketer of impla...	PDF Add to Briefcase File is in Briefcase
Dec 17, 2014	Second Sight's Argus® II Retinal Prosthetic Implant to be Sold in Turkey SYLMAR, Calif.--(BUSINESS WIRE)-- Second Sight Medical Products, Inc. (Nasdaq:EYES) ("Second Sight" or "the Company"), a developer, manufacturer and marketer of implantable visual prosthetics to restore some functional vision to blind patients, today announced that it has entered into an exclusive agreement with ...	PDF Add to Briefcase File is in Briefcase
Nov 24, 2014	Second Sight Announces Underwriter Exercises Over-Allotment Option SYLMAR, Calif., Nov. 24, 2014 (GLOBE NEWSWIRE) -- Second Sight Medical Products, Inc. (Nasdaq:EYES) ("Second Sight" or "the Company"), a developer, manufacturer and marketer of implantable visual prosthetics to restore some functional vision to blind patients, today announced that the underwriter for its initial public offering exercised its entire...	PDF Add to Briefcase File is in Briefcase
Nov 19, 2014	Second Sight Announces Pricing of Initial Public Offering SYLMAR, Calif., Nov. 19, 2014 (GLOBE NEWSWIRE) -- Second Sight Medical Products, Inc. ("Second Sight") today announced the pricing of its initial public offering of 3,500,000 shares of common stock, at a price of $9.00 per share. Second Sight develops, manufactures and markets implantable visual prosthetics to restore some functional vision to blin...	PDF Add to Briefcase File is in Briefcase
Sep 18, 2014	Second Sight Argus® II Retinal Prosthesis System to be trialled in blind dry AMD patients for the first time Lausanne, Switzerland, 18th of September 2014 – Second Sight Medical Products Inc. (Second Sight) today announces the world’s first ever study that aims to establish whether blind patients with total central vision loss due to dry Age-Related Macular Degeneration (AMD) can benefit from an artificial retina – th...	PDF Add to Briefcase File is in Briefcase
Aug 18, 2014	Second Sight Argus® II Retinal Prosthesis System wins financial support agreement in France	PDF Add to Briefcase File is in Briefcase
Mar 31, 2014	Second Sight Argus® II Retinal Prosthesis System is granted innovation funding by the French Ministry of Social Affairs and Health	PDF Add to Briefcase File is in Briefcase
Jan 29, 2014	Second Sight Announces First Commercial Implants of the Argus® II Retinal Prosthesis System In the United States Sylmar, CA, January 29, 2014 - Second Sight Medical Products Inc. (Second Sight) today announced that the Argus II Retinal Prosthesis System was implanted in patients with Retinitis Pigmentosa (RP) in the U.S. since it was approved by the U.S. Food and Drug Administration (FDA) last year. This follows the fir...	PDF Add to Briefcase File is in Briefcase
Oct 29, 2013	MD+DI, the Global MedTech Industry Authority, Announces the 2013 Medical Device Manufacturer of the Year	PDF Add to Briefcase File is in Briefcase
Sep 13, 2013	NHS England to consider reimbursing “bionic eye” treatment for blindness caused by retinitis pigmentosa	PDF Add to Briefcase File is in Briefcase
Aug 15, 2013	CMS Approves New Technology Add-on Payment and Pass-Through Payment for the Argus® II Retinal Prosthesis System Sylmar, CA- August 15, 2013 — Second Sight Medical Products, Inc., the leading developer of retinal prostheses for the blind, today announced that The Argus® II Retinal Prosthesis System (Argus II) has been approved by the Centers for Medicare and Medicaid Services (CMS) for both a new technology ...	PDF Add to Briefcase File is in Briefcase
Feb 14, 2013	Second Sight Medical Products Receives FDA Approval for Argus II System SYLMAR, CA, 14 February 2013 After more than 20 years of research and development, Second Sight Medical Products, Inc., the leading developer of retinal prostheses for the blind, is pleased to announce that it's Argus® II Retinal Prosthesis...	PDF Add to Briefcase File is in Briefcase
Oct 1, 2012	FDA Panel Recommends FDA Approval for Second Sight’s Argus® II Retinal Prosthesis System	PDF Add to Briefcase File is in Briefcase
Feb 7, 2012	Results from International Trial of Second Sight’s Argus® II Retinal Prosthesis System Published in Ophthalmology	PDF Add to Briefcase File is in Briefcase
Nov 2, 2011	Second Sight announces First Commercial Implant of Retinal Prosthesis	PDF Add to Briefcase File is in Briefcase
Oct 27, 2011	Second Sight wins 2011 World Technology Award	PDF Add to Briefcase File is in Briefcase
Sep 6, 2011	Second Sight announces that Argus II is now available in Germany	PDF Add to Briefcase File is in Briefcase
May 3, 2011	Second Sight Announces Significant Results from the Argus™ II Retina Prosthesis Trial at the ARVO 2011 Annual Meeting	PDF Add to Briefcase File is in Briefcase
Mar 2, 2011	Second Sight Medical Products Announces European Market Approval of a Retinal Prosthesis for the Blind	PDF Add to Briefcase File is in Briefcase
May 4, 2009	Second Sight to Double Patient Enrollment for Argus II Retinal Implant U.S. Clinical Trial	PDF Add to Briefcase File is in Briefcase
Nov 19, 2008	Second Sight Expands Int'l Clinical Trial for Argus II Retinal Implant	PDF Add to Briefcase File is in Briefcase
Feb 15, 2008	Second Sight Completes U.S. Phase I Enrollment and Commences European Clinical Trial for the Argus II Retinal Implant	PDF Add to Briefcase File is in Briefcase
Jan 9, 2007	Second Sight announces FDA approval to begin clinical trial to test newest generation of electronic retinal implant	PDF Add to Briefcase File is in Briefcase
Oct 14, 2004	Second Sight Medical Products Inc. announces DOE partnership to produce an Artificial Retina	PDF Add to Briefcase File is in Briefcase
Apr 30, 2002	Second Sight Announces Successful Retinal Prosthesis Implant	PDF Add to Briefcase File is in Briefcase

= add release to Briefcase

Investor Relations

Press Releases